Qing H Meng
Overview
Explore the profile of Qing H Meng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
119
Citations
2022
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Giannoli J, Vassault A, Carobene A, Liaudet A, Blasutig I, Dabla P, et al.
Clin Chim Acta
. 2025 Mar;
571:120240.
PMID: 40064457
This document describes the guidance on implementing and monitoring an IQC strategy that fulfills the requirements of the Standard ISO 15189:2022. It also explores the practical application of these principles...
2.
Gan Q, Ding Y, Wu Y, Zhang Y, Meng Q, Ding Q, et al.
Arch Pathol Lab Med
. 2025 Jan;
PMID: 39800878
Context.—: Objective.—: To report the isolation and significance of C kroppenstedtii, features of patients with GLM, pathologic findings and mechanism, bacteriologic workup, and optimal treatment. Design.—: Analysis of the cases...
3.
Meng Q, Halfdanarson T, Bornhorst J, Jann H, Shaheen S, Shi R, et al.
Clin Cancer Res
. 2024 Oct;
30(24):5559-5567.
PMID: 39453770
Purpose: Gastroenteropancreatic neuroendocrine tumors (GEP-NET) are relatively indolent but can be more aggressive. The current recommendations for using serum chromogranin A (CgA) for patients with GEP-NET are equivocal. This study...
4.
van Rossum H, Holdenrieder S, Yun Y, Patel D, Thelen M, Song J, et al.
Clin Chem Lab Med
. 2024 Sep;
PMID: 39299928
Objectives: CA 15-3 and CEA are tumor markers used in routine clinical care for breast cancer and colorectal cancer, among others. Current measurement procedures (MP) for these tumor markers are...
5.
Bais R, Vassault A, Blasutig I, Dabla P, Lin J, Perret-Liaudet A, et al.
Clin Chem Lab Med
. 2024 Sep;
62(12):2435-2443.
PMID: 39238208
Objectives: This study aimed to assess the validity of external quality assessment (EQA) laboratory results across various cultural and environmental contexts and to identify potential improvement areas. Methods: The International...
6.
Chen L, Zhang Y, Meng Q
Clin Chim Acta
. 2024 Aug;
564:119917.
PMID: 39181292
Hemolysis is the most prevalent pre-analytical interfering factor and a major source of error in laboratory analysis. The examination of samples post-centrifugation can provide valuable information regarding pre-analytical interferences. In...
7.
Gu J, Chery L, Nogueras Gonzalez G, Huff C, Strom S, Jones J, et al.
Prostate
. 2024 Mar;
84(7):694-705.
PMID: 38477020
Background: African American (AA) men have the highest incidence and mortality rates of prostate cancer (PCa) among all racial groups in the United States. While race is a social construct,...
8.
Zhang Y, Kumanovics A, Wiencek J, Melanson S, Love T, Wu A, et al.
Viruses
. 2024 Feb;
16(2.
PMID: 38400067
This study aimed to evaluate and compare the performance of three anti-S and one anti-N assays that were available to the project in detecting antibody levels after three commonly used...
9.
van Rossum H, Holdenrieder S, Ballieux B, Badrick T, Yun Y, Zhang C, et al.
Clin Chem
. 2024 Feb;
70(4):669-679.
PMID: 38385453
Background: The harmonization status of most tumor markers (TMs) is unknown. We report a feasibility study performed to determine whether external quality assessment (EQA) programs can be used to obtain...
10.
Ondracek C, Melanson S, Doan L, Schulz K, Kleinman S, Zhao Z, et al.
J Appl Lab Med
. 2023 Dec;
9(2):371-385.
PMID: 38059919
In 2021, the Association for Diagnostics & Laboratory Medicine (ADLM) (formerly the American Association for Clinical Chemistry [AACC]) developed a scientific study that aimed to contribute to the understanding of...